Leading IR Consultancy for Emerging Chinese Companies
HAIKOU CITY, Hainan, China, Oct. 21 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced the appointment of The Ruth Group (TRG) as its investor relations agency.
Ms. Zhilin Li, President and CEO of China Pharma Holdings, Inc., commented, "We look forward to working with The Ruth Group as our strategic, full-service investor relations team to enhance the visibility of China Pharma Holdings among the U.S. investment community. The Ruth Group's dedicated focus and expertise within the biopharmaceuticals industry has contributed to its successful track record providing top tier investor relations and public relations counsel for China-based, and healthcare companies. We will partner with TRG to position ourselves as China's premier biopharmaceutical company with a profitable low-cost, high margin business model and diverse, expanding product portfolio driven by the market demands of our region's rapidly growing healthcare industry."
Ms. Carol Ruth, President of The Ruth Group, stated, "We welcome the
opportunity to partner with China Pharma Holdings to raise the Company's
profile in the U.S. as we have done for emerging Chinese companies,
including Sinovac, JA Solar, SINA, and China TechFaith Wireless. Our
strategic messages will highlight China Pharma Holdings as a compelling
investment opportunity for U.S. value investors looking for profitable
biopharmaceutical companies with substantial growth potential. Our location
in New York City allows us to maintain close contact with the U.S.
healthcare investment community and ensures that our clients meet their
information requirements. In addition, our professional staff understands
how to close the information gap and be available in Asian time zones to
service our cl
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved